Table 2.
Placebo |
Nitrate |
Two-way ANOVA |
|||||
---|---|---|---|---|---|---|---|
Normoxia | Hypoxia | Normoxia | Hypoxia | Suppl. | Oxygen | Interaction | |
Thigh-cuff response | |||||||
Max. ΔMAP (%) | −26.0 ± 4.1 | −25.6 ± 4.6 | −26.9 ± 3.8 | −26.6 ± 3.8 | 0.525 | 0.683 | 0.913 |
Max. ΔICA flow (%) | −17.2 ± 2.3 | −21.2 ± 4.7a | −17.9 ± 2.7 | −21.8 ± 3.3a | 0.557 | <0.001 | 0.987 |
Dynamic CA variables (1–4 s after deflation) | |||||||
Slope of CVC | 0.041 ± 0.006 | 0.023 ± 0.008a | 0.040 ± 0.011 | 0.026 ± 0.004a | 0.646 | <0.001 | 0.345 |
ΔMAP (%) | −17.0 ± 3.0 | −16.7 ± 5.3 | −17.9 ± 3.5 | −17.1 ± 3.4 | 0.631 | 0.591 | 0.804 |
Note: Values are means ± SD.
aIndicates significant difference between normoxia and hypoxia within the same supplementation.
MAP: mean arterial pressure; ICA: internal carotid artery; CVC: cerebrovascular conductance; Suppl.: supplementation.